尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the complete record of transactions filed by du Monceau de Bergendal Fiona, Cadre supérieur. Director active across 1 company, notably UCB. Cumulatively, 1 disclosures have been logged. Activity tracked since 3 April 2026. The latest transaction was disclosed on 3 April 2026 (Purchase). Regulator: FSMA. The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Fiona du Monceau de Bergendal is a senior executive at UCB, a global biopharmaceutical company. She is responsible for managing operations and implementing the company's strategies. Her role is essential in ensuring operational efficiency and innovation within UCB, thereby contributing to the company's leadership position in the market.